Cargando…
Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144197/ https://www.ncbi.nlm.nih.gov/pubmed/21814496 http://dx.doi.org/10.1371/journal.pmed.1001063 |